{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:51:31Z","timestamp":1789829491285,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:00:00Z","timestamp":1794700800000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-21-851960"],"award-info":[{"award-number":["AARF-21-851960"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG078109 R35 AG071916"],"award-info":[{"award-number":["U19AG078109 R35 AG071916"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neurobiolaging.2025.11.005","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T20:26:49Z","timestamp":1763324809000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Depressive symptoms and plasma AT(N) biomarkers among cognitively healthy and mild cognitively impaired in a diverse cohort"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8186-8140","authenticated-orcid":false,"given":"Christina S.","family":"Dintica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sid","family":"O\u2019Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Yaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1177\/13872877251322966","article-title":"Association of Alzheimer\u2019s disease biomarkers with low premorbid intellectual functioning in a multi-ethnic community-dwelling cohort: A cross-sectional study of HABS-HD","volume":"104","author":"Abdullah","year":"2025","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib2","article-title":"Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid-negative subjects in the Alzheimer\u2019s disease continuum: a systematic review and meta-analysis","volume":"17","author":"Antonioni","year":"2025","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3233\/JAD-191078","article-title":"Depression is associated with tau and not amyloid positron emission tomography in cognitively normal adults","volume":"74","author":"Babulal","year":"2020","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib4","first-page":"637","article-title":"Clinical Dementia Rating (CDR)","volume":"24","author":"Berg","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib5","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1038\/s41380-025-02908-2","article-title":"The role of plasma inflammatory markers in late-life depression and conversion to dementia: a 3-year follow-up study","volume":"30","author":"Bocharova","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12883-023-03460-8","article-title":"Impairments in sleep and brain molecular clearance in people with cognitive deterioration and biological evidence of AD: a report of four cases","volume":"23","author":"Buongiorno","year":"2023","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-140324","article-title":"Depression in Alzheimer\u2019s Disease: epidemiology, mechanisms, and management","volume":"42","author":"Chi","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib9","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"2013"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib10","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3390\/cells10102581","article-title":"Inflammatory Cascade in Alzheimer\u2019s Disease Pathogenesis: a review of experimental findings","volume":"10","author":"De Oliveira","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1176\/appi.ajp.2017.17040442","article-title":"Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults","volume":"175","author":"Donovan","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-170001","article-title":"Depressive symptoms and tau accumulation in the inferior temporal lobe and entorhinal cortex in cognitively normal older adults: a pilot study","volume":"59","author":"Gatchel","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1192\/bjp.176.6.568","article-title":"Depression and risk of cognitive decline and Alzheimer\u2019s disease","volume":"176","author":"Geerlings","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib14","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/alz.12511","article-title":"Alzheimer\u2019s disease biomarkers in Black and non-Hispanic White cohorts: a contextualized review of the evidence","volume":"18","author":"Gleason","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1076\/clin.16.4.439.13908","article-title":"A verbal learning and memory test for english- and spanish-speaking older mexican-American Adults","volume":"16","author":"Gonz\u00e1lez","year":"2002","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib16","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and Cystatin C\u2013Based Equations to Estimate GFR without Race","volume":"385","author":"Inker","year":"2021","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-023-00640-5","article-title":"Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease","volume":"18","author":"Inoue","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41380-024-02672-9","article-title":"Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer\u2019s disease compared to comorbid cases; proof of concept in the ADNI study","volume":"30","author":"Ioannou","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib19","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1001\/jama.2019.7437","article-title":"Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia","volume":"321","author":"Jack","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1176\/appi.ajp.20220380","article-title":"Cerebral Small Vessel Disease Progression and the Risk of Dementia: a 14-Year Follow-Up Study","volume":"180","author":"Jacob","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib21","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-2275(20)38431-5","article-title":"Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism","volume":"29","author":"Kamboh","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fneur.2020.00927","article-title":"Cerebral small vessel disease and Alzheimer\u2019s disease: a review","volume":"11","author":"Kim","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib23","doi-asserted-by":"crossref","first-page":"25729","DOI":"10.18632\/aging.203790","article-title":"Factors influencing serum neurofilament light chain levels in normal aging","volume":"13","author":"Koini","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1440-1819.2010.02135.x","article-title":"Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression","volume":"64","author":"Kunugi","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib25","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/ijms26072940","article-title":"Chronic Stress-Associated Depressive Disorders: the impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus\u2014a Mini Review","volume":"26","author":"Lei","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib26","unstructured":"Lezak, M.D., Howieson, D.B., Loring, D.W., Hannay, H.J., Fischer, J.S., 2004. Neuropsychological assessment, 4th edNeuropsychological assessment4th ed.Oxford University PressNew York, NY, US."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1474439","article-title":"The role and mechanism of A\u03b2 clearance dysfunction in the glymphatic system in Alzheimer\u2019s disease comorbidity","volume":"15","author":"Li","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.biopsych.2020.06.017","article-title":"Late-LIfe Depression Is Associated with Reduced Cortical Amyloid Burden: findings from the Alzheimer\u2019s disease neuroimaging initiative depression project","volume":"89","author":"Mackin","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/07399863870092005","article-title":"Development of a short acculturation scale for hispanics","volume":"9","author":"Marin","year":"1987","journal-title":"Hisp. J. Behav. Sci."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamaneurol.2018.4249","article-title":"Assessment of racial disparities in biomarkers for Alzheimer Disease","volume":"76","author":"Morris","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib31","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/ijms25031596","article-title":"An interaction between brain-derived neurotrophic factor and stress-related glucocorticoids in the pathophysiology of Alzheimer\u2019s disease","volume":"25","author":"Numakawa","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","article-title":"Staging dementia using clinical dementia rating scale sum of boxes scores","volume":"65","author":"O\u2019Bryant","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/87565641.2017.1401628","article-title":"Texas mexican American adult normative studies: normative data for commonly used clinical neuropsychological measures for english- and Spanish-speakers","volume":"43","author":"O\u2019Bryant","year":"2018","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib34","first-page":"13","article-title":"The health & aging brain among Latino Elders (HABLE) study methods and participant characteristics. Alzheimers Dement. diagn. assess","author":"O\u2019Bryant","year":"2021","journal-title":"Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2010.115","article-title":"Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer\u2019s coordinating center database","volume":"67","author":"O\u2019Bryant","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnagi.2019.00043","article-title":"High COrtisol and the Risk of Dementia and Alzheimer\u2019s disease: a review of the literature","volume":"11","author":"Ouanes","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What\u2019s wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3233\/JAD-170041","article-title":"Cortical thickness and depressive symptoms in cognitively normal individuals: the mayo clinic study of aging","volume":"58","author":"Pink","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/brainsci10110868","article-title":"The sleeping brain: harnessing the power of the glymphatic system through lifestyle choices","volume":"10","author":"Reddy","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiol. Camb. Mass"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gps.2697","article-title":"Depressive symptoms predict longitudinal change in executive control but not memory","volume":"27","author":"Royall","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103322","article-title":"Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment","volume":"37","author":"Smith","year":"2023","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14397","article-title":"Plasma p-tau immunoassays in clinical research for Alzheimer\u2019s disease","volume":"21","author":"Teunissen","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib44","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jagp.2024.03.004","article-title":"Depressive symptoms and plasma markers of Alzheimer\u2019s disease and neurodegeneration: a coordinated meta-analysis of 8 cohort studies","volume":"32","author":"Twait","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib45","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: mechanisms and clinical implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib46","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00259-013-2627-0","article-title":"Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45\/Amyvid) positron emission tomography","volume":"41","author":"Wu","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.796867","article-title":"The impact of systemic inflammation on Alzheimer\u2019s disease pathology","volume":"12","author":"Xie","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neurobiolaging.2025.11.005_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J. Psychiatr. Res."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025002003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025002003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:22:59Z","timestamp":1766096579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458025002003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"alternative-id":["S0197458025002003"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.11.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depressive symptoms and plasma AT(N) biomarkers among cognitively healthy and mild cognitively impaired in a diverse cohort","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}